China (People’s Republic of) vs Sri Lanka: Pneumococcal conjugate second or third-dose vaccines (PCVc)
China (People’s Republic of)
0.0%
in 2025
Sri Lanka
0.0%
in 2025
China (People’s Republic of) rank
165th
Sri Lanka rank
165th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- China (People’s Republic of)
- Sri Lanka
How they compare
China (People’s Republic of) currently reports 0.0% against 0.0% in Sri Lanka, a difference of 0.0%.
Across all 18 years both countries report, Sri Lanka has been ahead every year.
China (People’s Republic of) ranks 165th and Sri Lanka ranks 165th of 192 countries.
Head to head by decade
| Decade | China (People’s Republic of) | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), China (People’s Republic of) or Sri Lanka?
- China (People’s Republic of), at 0.0% against 0.0% in Sri Lanka as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between China (People’s Republic of) and Sri Lanka?
- 0.0%, with China (People’s Republic of) ahead.
- How many years of comparable data are there for China (People’s Republic of) and Sri Lanka?
- 18 years are reported by both, from 2008 to 2025.
- How do China (People’s Republic of) and Sri Lanka rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- China (People’s Republic of) ranks 165th and Sri Lanka ranks 165th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.